Avantor, Inc.
AVTR Mid CapHealthcare · Medical Instruments & Supplies
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Avantor, Inc. en bref
Avantor, Inc. (AVTR) is currently trading at 8,35 € with a market capitalization of 5,7 Md €. The 52-week range spans from 6,34 € to 13,90 €; the current price is 39.9% below the yearly high.
💰 Dividende
Avantor, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
15 analystes évaluent Avantor, Inc. (AVTR) au consensus : None. L'objectif de cours moyen est de 8,44 €, soit un potentiel de +1.01% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 6,11 € à 16,58 €.
Avantor, Inc. : la thèse d'investissement en détail
Avantor, Inc. (AVTR) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario baissier
Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.
Thèse d'investissement : forces et faiblesses
- Free cash flow positif
- –Actuellement non rentable
Aperçu technique
The price is in a transition zone relative to the moving averages — no clear signal.
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (7.21%).
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Avantor, Inc.?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
